-
US-brokered truce begins in Ukraine city occupied by Russia
-
New Zealand ex-PM Ardern to teach leadership in Sydney
-
Qatar launches Fashion and Crafts Council to connect talent with global markets
-
Ballon d'Or 'beyond wildest dreams' but Kane has plenty more to prove
-
Jordan strikes militant groups in Syria after church attack
-
No envy, no secrets: How Spain's Gipuzkoa became football coaching hotbed
-
FIA chief praises Middle East motorsport volunteers and officials
-
South Korea economy grows three times faster than expected in Q3
-
Australia warns of 'unprecedented' AI threat
-
Al-Thawadi urges technology to deepen human connection through shared experiences
-
Qatar Amir arrives in Moscow for eighth GECF summit
-
Ballon d'Or: Harry Kane's crowning moment
-
Kane beats Yamal and Mbappe to taste Ballon d'Or glory
-
Harry Kane wins men's Ballon d'Or
-
Ballon d'Or crowns Putellas's return to top of women's game
-
Lula win rattles Brazil markets over spending spree fears
-
Godts stars as PSG beat Lyon to go top of Ligue 1
-
De la Fuente wins men's Ballon d'Or coach of year
-
NBA inks deal with Kalshi and Polymarket, citing safeguards
-
Trump slams 'rigged' Brazil election after ally loses to leftist Lula
-
US rapper Macklemore launches 'Free Palestine Tour' after Ed Sheeran fallout
-
Nadal returns for Vegas hardcourt event
-
Venezuela leader criticizes Machado over dramatic return from exile
-
Fainga'anuku named as loose forward for All Blacks northern tour
-
Brazil markets battered after Lula win, AI in focus elsewhere
-
Anthropic points to AI dangers, soaring sales in IPO filing
-
Lula savors Brazil win as Bolsonaro rejects result, markets tumble
-
Sinner to play rescheduled Saudi Six Kings in December
-
Canadian youths ask court to impose binding climate protections
-
Brazilian lawmaker Andre Janones, Lula's social media 'general'
-
Walter Koenig, who played original Chekov on 'Star Trek,' dies at 90
-
Swiss Ebola patient repatriated from Nigeria
-
Netanyahu, rivals trade attacks over Iran as clock counts down to Israel vote
-
Nations far from a deal as UN nature talks enter final stretch
-
Townsend urges Scotland to use Nations Championship as World Cup springboard
-
Brazil markets battered, tech in focus elsewhere
-
Microsoft offers voluntary exit packages to 60,000 staff
-
French court adjourns trial over 2020 death of delivery driver
-
S.Africa ambassador calls for talks with US over 'tense' ties
-
Serbian student movement eyes power after election triumph
-
'Smells of freedom': Serbians hopeful after landmark election
-
Machado ready to meet Venezuela leader after shock return
-
South Africa select 'enforcer' Coetzee for Australia decider
-
Lula celebrates election win as Brazil markets tumble
-
Botanists comb Gabon's rich rainforests with nature on the line
-
France's Macron accuses social media of sowing discord ahead of election
-
New levy on non-EU parcels kicks in Sunday
-
Anthropic unveils IPO filing showing soaring sales and AI risks
-
Stocks climb ahead of tech earnings, central bank calls
-
US singer Chris Brown avoids jail over London nightclub brawl
New Zealand approves medicinal use of 'magic mushrooms'
New Zealand on Wednesday approved the medicinal use of psilocybin, a hallucinogenic compound notably found in so-called "magic mushrooms".
Deputy Prime Minister David Seymour said rules had been relaxed so psilocybin could be used to treat certain types of depression.
Psilocybin is a naturally occurring psychedelic compound found in some species of mushroom and can cause hallucinations and an altered state of mind.
"Psilocybin remains an unapproved medicine, but a highly experienced psychiatrist has been granted authority to prescribe it to patients with treatment-resistant depression," Seymour said.
"This is huge for people with depression who've tried everything else and are still suffering.
"If a doctor believes psilocybin can help, they should have the tools to try."
There will be tight rules for prescribing the drug.
Only psychiatrists who have been involved in psilocybin clinical trials will be allowed to prescribe it, and they must strictly report its use and keep detailed records.
Party drugs such as as MDMA and magic mushrooms are increasingly being used in mainstream medical settings, helping treat post-traumatic stress disorder and depression.
Australia approved the medicinal use of psilocybin in 2023.
A.Anderson--AT